Jeffrey E Rubnitz Selected Research

Jeffrey E Rubnitz Research Topics

Disease

44	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 10/2002
26	Leukemia 01/2022 - 07/2002
23	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 07/2002
18	Neoplasms (Cancer) 01/2022 - 04/2004
15	Residual Neoplasm 06/2021 - 02/2003
10	Infections 10/2022 - 04/2008
5	Sepsis (Septicemia) 10/2020 - 07/2008
4	Febrile Neutropenia 07/2014 - 04/2008
3	Osteonecrosis (Kienbock's Disease) 01/2017 - 06/2009
3	Mycoses (Diseases, Fungus) 12/2013 - 07/2008
2	Chromosome Aberrations (Chromosome Abnormalities) 06/2021 - 12/2016
2	Philadelphia Chromosome 01/2021 - 05/2014
2	Bacteremia 10/2020 - 07/2014
2	Exanthema (Rash) 12/2019 - 08/2011
2	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 01/2019 - 11/2012
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 09/2011
2	Thrombosis (Thrombus) 01/2017 - 06/2009
2	Neutropenia 03/2011 - 07/2008
1	De Lange Syndrome (Cornelia De Lange Syndrome) 01/2022
1	Neuroblastoma 01/2022
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Genomic Instability 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Reinfection 10/2020
1	Cardiomyopathies (Cardiomyopathy) 10/2019
1	Second Primary Neoplasms (Neoplasms, Second) 10/2019
1	Methemoglobinemia 01/2019
1	Glucosephosphate Dehydrogenase Deficiency 01/2019
1	Oncogene Addiction 01/2018
1	Clostridium Infections 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Pain (Aches) 09/2017
1	Hyperglycemia 01/2017
1	Hypokalemia 01/2017
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2016

Drug/Important Bio-Agent (IBA)

15	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2021 - 10/2002
6	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 06/2011
6	Biological ProductsIBA 11/2021 - 02/2007
5	Asparaginase (Elspar)FDA Link 01/2022 - 05/2009
5	Etoposide (VP 16)FDA LinkGeneric 10/2019 - 11/2004
4	Clofarabine (Clolar)FDA Link 12/2019 - 08/2011
3	Core Binding Factors (Core-Binding Factor)IBA 06/2021 - 03/2012
3	Vancomycin FDA LinkGeneric 10/2020 - 07/2008
3	fms-Like Tyrosine Kinase 3IBA 11/2019 - 10/2013
3	GlucocorticoidsIBA 01/2017 - 05/2009
3	Gemtuzumab (Mylotarg)FDA Link 08/2014 - 03/2013
3	Cladribine FDA LinkGeneric 01/2010 - 10/2002
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 05/2014
2	venetoclaxIBA 01/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2020 - 07/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2019 - 01/2012
2	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2019 - 05/2013
2	Arabinofuranosylcytosine TriphosphateIBA 01/2018 - 10/2002
2	Phosphotransferases (Kinase)IBA 01/2018 - 06/2011
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017 - 11/2004
2	Indicators and Reagents (Reagents)IBA 04/2015 - 07/2002
2	Methotrexate (Mexate)FDA LinkGeneric 03/2014 - 07/2013
2	Voriconazole (Vfend)FDA LinkGeneric 12/2013 - 07/2008
2	Messenger RNA (mRNA)IBA 09/2013 - 10/2011
2	Proteins (Proteins, Gene)FDA Link 11/2012 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 03/2011 - 08/2006
2	Pharmaceutical PreparationsIBA 11/2010 - 11/2004
1	CPX-351IBA 01/2022
1	crenolanibIBA 01/2022
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2022
1	ProteomeIBA 06/2021
1	navitoclaxIBA 01/2021
1	PanobinostatIBA 11/2020
1	CoagulaseIBA 10/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 12/2019
1	AnthracyclinesIBA 10/2019
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2019
1	Janus Kinase InhibitorsIBA 01/2019
1	rasburicase (Elitek)FDA Link 01/2019
1	ProdrugsIBA 01/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	Opioid Analgesics (Opioids)IBA 09/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	AlbuminsIBA 01/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017
1	CholesterolIBA 01/2017
1	AntibodiesIBA 01/2017
1	selinexorIBA 12/2016
1	fludarabineIBA 12/2016

Therapy/Procedure

37	Therapeutics 10/2022 - 02/2003
23	Drug Therapy (Chemotherapy) 01/2022 - 07/2002
8	Remission Induction 10/2019 - 07/2002
3	Cranial Irradiation 12/2019 - 11/2004
3	Cell Transplantation 08/2015 - 07/2011
3	Transplantation 08/2011 - 02/2010
2	Aftercare (After-Treatment) 10/2022 - 03/2007
2	Immunotherapy 01/2021 - 04/2015
2	Catheters 01/2018 - 01/2015
2	Hematopoietic Stem Cell Transplantation 01/2015 - 02/2008
2	Antibiotic Prophylaxis 07/2014 - 07/2008
2	Induction Chemotherapy 05/2014 - 03/2011
2	Combination Drug Therapy (Combination Chemotherapy) 07/2013 - 01/2012